Stereotaxis swaps out Hogg as CEO

Stereotaxis, a manufacturer of cardiology instrument control systems, has announced that Michael Kaminski, currently president and chief operations officer (COO) and a member of the board, will assume the title and responsibilities of CEO, effective Jan. 1, 2009.

Kaminski will replace Bevil Hogg, who has served as the CEO since 1997 and will remain a member of the company's board of directors.

The St. Louis-based Stereotaxis said that Kaminski came on board in April 2002 as COO. Prior to that, Kaminski spent nearly 20 years with Batesville, Ind.-based Hill-Rom, a provider of hospital and home healthcare equipment.  

"We have reached a point where my own expertise in creating a new technology and the organization to support it should ideally be succeeded by a leader who brings the experience, expertise and focus necessary for operational execution and who can lead Stereotaxis to greater commercial success,” according to Hogg.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.